Structure

Physi-Chem Properties

Molecular Weight:  335.18
Volume:  355.512
LogP:  4.049
LogD:  3.484
LogS:  -3.021
# Rotatable Bonds:  3
TPSA:  31.92
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.753
Synthetic Accessibility Score:  2.406
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.799
MDCK Permeability:  1.389020872011315e-05
Pgp-inhibitor:  0.956
Pgp-substrate:  0.991
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.983
Plasma Protein Binding (PPB):  77.36504364013672%
Volume Distribution (VD):  2.853
Pgp-substrate:  17.404590606689453%

ADMET: Metabolism

CYP1A2-inhibitor:  0.917
CYP1A2-substrate:  0.929
CYP2C19-inhibitor:  0.646
CYP2C19-substrate:  0.615
CYP2C9-inhibitor:  0.511
CYP2C9-substrate:  0.467
CYP2D6-inhibitor:  0.973
CYP2D6-substrate:  0.923
CYP3A4-inhibitor:  0.953
CYP3A4-substrate:  0.538

ADMET: Excretion

Clearance (CL):  8.612
Half-life (T1/2):  0.079

ADMET: Toxicity

hERG Blockers:  0.975
Human Hepatotoxicity (H-HT):  0.376
Drug-inuced Liver Injury (DILI):  0.688
AMES Toxicity:  0.164
Rat Oral Acute Toxicity:  0.868
Maximum Recommended Daily Dose:  0.933
Skin Sensitization:  0.639
Carcinogencity:  0.045
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470233

Natural Product ID:  NPC470233
Common Name*:  
IUPAC Name:   4-[2-(4-fluorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrrol-3-yl]pyridine
Synonyms:  
Standard InCHIKey:  RBWNFHXBUDPAIO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H22FN3/c1-25-12-8-16(9-13-25)20-14-19(15-6-10-23-11-7-15)21(24-20)17-2-4-18(22)5-3-17/h2-7,10-11,14,16,24H,8-9,12-13H2,1H3
SMILES:  CN1CCC(CC1)c1[nH]c(c(c1)c1ccncc1)c1ccc(cc1)F
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL190228
PubChem CID:   500899
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000090] Pyrroles
        • [CHEMONTID:0002257] Substituted pyrroles
          • [CHEMONTID:0002334] Phenylpyrroles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33124 Diaporthe Genus Diaporthaceae Eukaryota n.a. n.a. n.a. PMID[15844962]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[16562839]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[16643061]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota giant jellyfish Nemopilema nomurai n.a. n.a. PMID[22483395]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[26651221]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[30785282]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[31120749]
NPO32661 Phoma sp. Species Didymellaceae Eukaryota n.a. n.a. n.a. PMID[7561907]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6488 Individual Protein cGMP-dependent protein kinase Eimeria tenella IC50 = 0.7 nM PMID[548233]
NPT6488 Individual Protein cGMP-dependent protein kinase Eimeria tenella IC50 < 1.0 nM PMID[548234]
NPT6433 Individual Protein CGMP-dependent protein kinase Plasmodium falciparum IC50 = 8.0 nM PMID[548237]
NPT6433 Individual Protein CGMP-dependent protein kinase Plasmodium falciparum IC50 = 6.0 nM PMID[548242]
NPT3129 Organism Eimeria tenella Eimeria tenella Activity >= 80.0 % PMID[548233]
NPT3128 Organism Eimeria acervulina Eimeria acervulina Activity >= 80.0 % PMID[548233]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii IC50 = 210000.0 nM PMID[548234]
NPT2 Others Unspecified IC50 < 1.0 nM PMID[548235]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii IC50 = 210.0 nM PMID[548235]
NPT474 Organism Plasmodium berghei Plasmodium berghei INH > 1.0 uM PMID[548236]
NPT474 Organism Plasmodium berghei Plasmodium berghei Activity = 50.0 % PMID[548236]
NPT474 Organism Plasmodium berghei Plasmodium berghei FC > 1000.0 n.a. PMID[548236]
NPT475 Organism Plasmodium yoelii Plasmodium yoelii FC > 1000.0 n.a. PMID[548236]
NPT475 Organism Plasmodium yoelii Plasmodium yoelii TIME = 127.92 hr PMID[548236]
NPT474 Organism Plasmodium berghei Plasmodium berghei Inhibition > 90.0 % PMID[548238]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 > 50000.0 nM PMID[548239]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii Inhibition = 100.0 % PMID[548239]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii Inhibition = 99.3 % PMID[548239]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii Inhibition = 100.0 uM PMID[548239]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii Inhibition = 97.86 uM PMID[548239]
NPT486 Organism Toxoplasma gondii Toxoplasma gondii IC50 = 1210.0 nM PMID[548239]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1300.0 nM PMID[548241]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 490.0 nM PMID[548241]
NPT2 Others Unspecified IC50 = 3.5 nM PMID[548241]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 450.0 nM PMID[548242]
NPT20556 SINGLE PROTEIN Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 9.51 % PMID[548243]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.11 % PMID[548244]
NPT22194 ORGANISM Naegleria gruberi Naegleria gruberi Inhibition n.a. 0.0 % PMID[548245]
NPT20 Organism Candida albicans Candida albicans Inhibition = 0.45 % PMID[548246]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans Inhibition = 8.69 % PMID[548246]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = -2.15 % PMID[548246]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 5.43 % PMID[548246]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 4.09 % PMID[548246]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = 12.09 % PMID[548246]
NPT2922 Organism Staphylococcus aureus subsp. aureus Staphylococcus aureus subsp. aureus Inhibition = -0.65 % PMID[548246]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470233 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8889 High Similarity NPC73767
0.8859 High Similarity NPC53947
0.8851 High Similarity NPC201380
0.8851 High Similarity NPC179787
0.8828 High Similarity NPC469768
0.8828 High Similarity NPC469779
0.8828 High Similarity NPC469767
0.8828 High Similarity NPC469780
0.8828 High Similarity NPC469784
0.8828 High Similarity NPC469761
0.8828 High Similarity NPC469783
0.8792 High Similarity NPC321911
0.8784 High Similarity NPC63545
0.8767 High Similarity NPC469766
0.8759 High Similarity NPC110126
0.8758 High Similarity NPC56765
0.875 High Similarity NPC84911
0.8742 High Similarity NPC325903
0.8725 High Similarity NPC469811
0.8681 High Similarity NPC29886
0.8681 High Similarity NPC96102
0.8681 High Similarity NPC261195
0.8658 High Similarity NPC288838
0.863 High Similarity NPC88097
0.8625 High Similarity NPC280852
0.8621 High Similarity NPC105127
0.8609 High Similarity NPC40070
0.86 High Similarity NPC21605
0.8581 High Similarity NPC215584
0.8581 High Similarity NPC44773
0.8571 High Similarity NPC216643
0.8571 High Similarity NPC59084
0.8516 High Similarity NPC206819
0.8516 High Similarity NPC318065
0.8514 High Similarity NPC63157
0.8514 High Similarity NPC473868
0.8493 Intermediate Similarity NPC251722
0.8493 Intermediate Similarity NPC314102
0.8483 Intermediate Similarity NPC198988
0.8471 Intermediate Similarity NPC90723
0.8467 Intermediate Similarity NPC314372
0.8456 Intermediate Similarity NPC190296
0.8452 Intermediate Similarity NPC286427
0.8452 Intermediate Similarity NPC236711
0.8446 Intermediate Similarity NPC279081
0.8446 Intermediate Similarity NPC2949
0.8408 Intermediate Similarity NPC470203
0.8403 Intermediate Similarity NPC82295
0.8397 Intermediate Similarity NPC41257
0.8366 Intermediate Similarity NPC105818
0.8366 Intermediate Similarity NPC24678
0.8354 Intermediate Similarity NPC317105
0.8344 Intermediate Similarity NPC470204
0.8344 Intermediate Similarity NPC122141
0.8344 Intermediate Similarity NPC229173
0.8322 Intermediate Similarity NPC230002
0.8299 Intermediate Similarity NPC325252
0.8289 Intermediate Similarity NPC143872
0.828 Intermediate Similarity NPC474880
0.828 Intermediate Similarity NPC475990
0.828 Intermediate Similarity NPC221786
0.828 Intermediate Similarity NPC92796
0.828 Intermediate Similarity NPC135141
0.8258 Intermediate Similarity NPC469765
0.8258 Intermediate Similarity NPC259644
0.8258 Intermediate Similarity NPC73952
0.8258 Intermediate Similarity NPC25008
0.8258 Intermediate Similarity NPC200214
0.8258 Intermediate Similarity NPC469760
0.8258 Intermediate Similarity NPC469763
0.8258 Intermediate Similarity NPC469786
0.8247 Intermediate Similarity NPC33421
0.8243 Intermediate Similarity NPC150259
0.8235 Intermediate Similarity NPC470111
0.8235 Intermediate Similarity NPC471957
0.8224 Intermediate Similarity NPC159856
0.821 Intermediate Similarity NPC82331
0.8207 Intermediate Similarity NPC22079
0.8205 Intermediate Similarity NPC211572
0.8205 Intermediate Similarity NPC476219
0.8205 Intermediate Similarity NPC70922
0.8205 Intermediate Similarity NPC80597
0.8205 Intermediate Similarity NPC212376
0.8205 Intermediate Similarity NPC75540
0.82 Intermediate Similarity NPC115611
0.8171 Intermediate Similarity NPC474958
0.8151 Intermediate Similarity NPC475450
0.8148 Intermediate Similarity NPC194411
0.8105 Intermediate Similarity NPC86288
0.8092 Intermediate Similarity NPC20144
0.8089 Intermediate Similarity NPC34844
0.8082 Intermediate Similarity NPC475428
0.8077 Intermediate Similarity NPC470823
0.8075 Intermediate Similarity NPC274229
0.8056 Intermediate Similarity NPC250361
0.8038 Intermediate Similarity NPC469785
0.8037 Intermediate Similarity NPC474897
0.8025 Intermediate Similarity NPC141926
0.8025 Intermediate Similarity NPC474561
0.8025 Intermediate Similarity NPC49954
0.8014 Intermediate Similarity NPC473587
0.8012 Intermediate Similarity NPC271797
0.8012 Intermediate Similarity NPC21174
0.8 Intermediate Similarity NPC275305
0.8 Intermediate Similarity NPC37423
0.7987 Intermediate Similarity NPC469762
0.7987 Intermediate Similarity NPC470440
0.7986 Intermediate Similarity NPC146373
0.7986 Intermediate Similarity NPC245244
0.7986 Intermediate Similarity NPC166424
0.7975 Intermediate Similarity NPC63751
0.7973 Intermediate Similarity NPC473930
0.7972 Intermediate Similarity NPC46358
0.7965 Intermediate Similarity NPC231536
0.7962 Intermediate Similarity NPC216713
0.7959 Intermediate Similarity NPC69914
0.7959 Intermediate Similarity NPC282398
0.7945 Intermediate Similarity NPC473762
0.7939 Intermediate Similarity NPC477611
0.7933 Intermediate Similarity NPC218268
0.7927 Intermediate Similarity NPC97343
0.7917 Intermediate Similarity NPC476322
0.7917 Intermediate Similarity NPC27740
0.7914 Intermediate Similarity NPC160105
0.7905 Intermediate Similarity NPC179365
0.7904 Intermediate Similarity NPC68354
0.7902 Intermediate Similarity NPC41174
0.7901 Intermediate Similarity NPC478182
0.7901 Intermediate Similarity NPC311276
0.7895 Intermediate Similarity NPC316811
0.7895 Intermediate Similarity NPC315348
0.7895 Intermediate Similarity NPC32002
0.7892 Intermediate Similarity NPC471579
0.7891 Intermediate Similarity NPC476131
0.7879 Intermediate Similarity NPC201634
0.7872 Intermediate Similarity NPC91958
0.7871 Intermediate Similarity NPC204141
0.7866 Intermediate Similarity NPC201700
0.7862 Intermediate Similarity NPC476297
0.7857 Intermediate Similarity NPC215795
0.7857 Intermediate Similarity NPC176199
0.7843 Intermediate Similarity NPC284635
0.784 Intermediate Similarity NPC478185
0.784 Intermediate Similarity NPC282231
0.784 Intermediate Similarity NPC225018
0.7832 Intermediate Similarity NPC182570
0.7832 Intermediate Similarity NPC265605
0.7832 Intermediate Similarity NPC48564
0.7829 Intermediate Similarity NPC169433
0.7812 Intermediate Similarity NPC51054
0.7811 Intermediate Similarity NPC314919
0.7799 Intermediate Similarity NPC138842
0.7798 Intermediate Similarity NPC59269
0.7791 Intermediate Similarity NPC478184
0.7791 Intermediate Similarity NPC40779
0.7778 Intermediate Similarity NPC329825
0.7778 Intermediate Similarity NPC279918
0.7778 Intermediate Similarity NPC104483
0.7765 Intermediate Similarity NPC307191
0.7763 Intermediate Similarity NPC125746
0.7758 Intermediate Similarity NPC317430
0.7725 Intermediate Similarity NPC314603
0.7725 Intermediate Similarity NPC472123
0.7716 Intermediate Similarity NPC293487
0.7716 Intermediate Similarity NPC477591
0.7707 Intermediate Similarity NPC316069
0.7702 Intermediate Similarity NPC476464
0.7697 Intermediate Similarity NPC56233
0.7697 Intermediate Similarity NPC49217
0.7692 Intermediate Similarity NPC151939
0.7683 Intermediate Similarity NPC149265
0.7683 Intermediate Similarity NPC194640
0.7676 Intermediate Similarity NPC240136
0.7676 Intermediate Similarity NPC297486
0.7676 Intermediate Similarity NPC471402
0.7669 Intermediate Similarity NPC131718
0.7667 Intermediate Similarity NPC101165
0.7662 Intermediate Similarity NPC312092
0.7661 Intermediate Similarity NPC191415
0.7658 Intermediate Similarity NPC477134
0.7657 Intermediate Similarity NPC95783
0.7654 Intermediate Similarity NPC265576
0.7654 Intermediate Similarity NPC129721
0.7651 Intermediate Similarity NPC329896
0.7651 Intermediate Similarity NPC475090
0.7651 Intermediate Similarity NPC475105
0.7636 Intermediate Similarity NPC17751
0.7636 Intermediate Similarity NPC280864
0.7622 Intermediate Similarity NPC143603
0.7619 Intermediate Similarity NPC161861
0.761 Intermediate Similarity NPC2272
0.761 Intermediate Similarity NPC37548
0.7607 Intermediate Similarity NPC230869
0.7602 Intermediate Similarity NPC300688
0.759 Intermediate Similarity NPC478183
0.759 Intermediate Similarity NPC54988
0.7588 Intermediate Similarity NPC248454
0.7586 Intermediate Similarity NPC94752
0.7584 Intermediate Similarity NPC89490
0.758 Intermediate Similarity NPC242556

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470233 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9653 High Similarity NPD2837 Discontinued
0.9028 High Similarity NPD1722 Approved
0.9013 High Similarity NPD1853 Clinical (unspecified phase)
0.8759 High Similarity NPD786 Approved
0.8725 High Similarity NPD4547 Phase 3
0.871 High Similarity NPD3323 Discontinued
0.8681 High Similarity NPD198 Clinical (unspecified phase)
0.8667 High Similarity NPD4374 Clinical (unspecified phase)
0.8667 High Similarity NPD3100 Discontinued
0.858 High Similarity NPD6277 Clinical (unspecified phase)
0.8543 High Similarity NPD2430 Phase 2
0.8511 High Similarity NPD2119 Approved
0.8511 High Similarity NPD2118 Approved
0.8462 Intermediate Similarity NPD3476 Approved
0.8462 Intermediate Similarity NPD3475 Approved
0.8414 Intermediate Similarity NPD3944 Approved
0.8414 Intermediate Similarity NPD3942 Approved
0.8366 Intermediate Similarity NPD2172 Phase 1
0.8333 Intermediate Similarity NPD1192 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD4637 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD3610 Approved
0.8323 Intermediate Similarity NPD3609 Approved
0.8322 Intermediate Similarity NPD3943 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD2640 Approved
0.8313 Intermediate Similarity NPD2641 Approved
0.8291 Intermediate Similarity NPD2385 Clinical (unspecified phase)
0.8288 Intermediate Similarity NPD4030 Approved
0.8288 Intermediate Similarity NPD3385 Approved
0.8288 Intermediate Similarity NPD4028 Approved
0.8288 Intermediate Similarity NPD4029 Approved
0.8214 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD2006 Phase 2
0.8182 Intermediate Similarity NPD3341 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD5254 Discontinued
0.8125 Intermediate Similarity NPD991 Phase 2
0.8125 Intermediate Similarity NPD992 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD4181 Approved
0.811 Intermediate Similarity NPD5065 Approved
0.8092 Intermediate Similarity NPD2007 Clinical (unspecified phase)
0.8082 Intermediate Similarity NPD715 Phase 3
0.8059 Intermediate Similarity NPD5590 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD5436 Phase 1
0.8 Intermediate Similarity NPD1403 Approved
0.8 Intermediate Similarity NPD1404 Approved
0.7987 Intermediate Similarity NPD4880 Discontinued
0.7975 Intermediate Similarity NPD976 Approved
0.7975 Intermediate Similarity NPD975 Approved
0.7975 Intermediate Similarity NPD977 Approved
0.7975 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD4779 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD4075 Phase 2
0.7941 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD1683 Approved
0.7914 Intermediate Similarity NPD2642 Approved
0.7914 Intermediate Similarity NPD2639 Approved
0.7904 Intermediate Similarity NPD3505 Approved
0.7904 Intermediate Similarity NPD3506 Approved
0.7895 Intermediate Similarity NPD2069 Approved
0.7895 Intermediate Similarity NPD2074 Approved
0.7895 Intermediate Similarity NPD768 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD2073 Approved
0.7895 Intermediate Similarity NPD2068 Approved
0.7895 Intermediate Similarity NPD2072 Approved
0.7895 Intermediate Similarity NPD2075 Approved
0.7895 Intermediate Similarity NPD2071 Approved
0.7895 Intermediate Similarity NPD2070 Approved
0.7895 Intermediate Similarity NPD3378 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD4128 Approved
0.7891 Intermediate Similarity NPD3654 Approved
0.7881 Intermediate Similarity NPD45 Approved
0.7881 Intermediate Similarity NPD6554 Approved
0.7866 Intermediate Similarity NPD2185 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD5145 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD4076 Approved
0.7857 Intermediate Similarity NPD4079 Approved
0.784 Intermediate Similarity NPD5315 Discontinued
0.7832 Intermediate Similarity NPD270 Clinical (unspecified phase)
0.7832 Intermediate Similarity NPD268 Approved
0.7832 Intermediate Similarity NPD271 Approved
0.7821 Intermediate Similarity NPD7469 Discontinued
0.7818 Intermediate Similarity NPD4184 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD2580 Discontinued
0.7808 Intermediate Similarity NPD9583 Approved
0.7806 Intermediate Similarity NPD1918 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD3339 Approved
0.7798 Intermediate Similarity NPD7111 Discontinued
0.7798 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD4463 Approved
0.7785 Intermediate Similarity NPD4462 Approved
0.7771 Intermediate Similarity NPD5934 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD5806 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD2865 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD4326 Phase 2
0.7751 Intermediate Similarity NPD2930 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD2165 Phase 1
0.7746 Intermediate Similarity NPD3486 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD6278 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD6595 Phase 3
0.7702 Intermediate Similarity NPD3112 Approved
0.7702 Intermediate Similarity NPD3115 Approved
0.7702 Intermediate Similarity NPD3113 Approved
0.7702 Intermediate Similarity NPD3114 Approved
0.7702 Intermediate Similarity NPD473 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1253 Approved
0.7697 Intermediate Similarity NPD1255 Approved
0.7697 Intermediate Similarity NPD1254 Approved
0.7697 Intermediate Similarity NPD1256 Approved
0.7688 Intermediate Similarity NPD6217 Discontinued
0.7674 Intermediate Similarity NPD6178 Phase 3
0.7671 Intermediate Similarity NPD9357 Approved
0.767 Intermediate Similarity NPD4615 Phase 2
0.7669 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD4649 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD4702 Approved
0.7658 Intermediate Similarity NPD4703 Approved
0.7654 Intermediate Similarity NPD6497 Approved
0.7651 Intermediate Similarity NPD2333 Discontinued
0.7651 Intermediate Similarity NPD5862 Discovery
0.765 Intermediate Similarity NPD4023 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1262 Discovery
0.764 Intermediate Similarity NPD2960 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD6771 Discontinued
0.7616 Intermediate Similarity NPD5105 Approved
0.7616 Intermediate Similarity NPD5106 Approved
0.7616 Intermediate Similarity NPD5728 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD3419 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD5418 Discontinued
0.7605 Intermediate Similarity NPD4024 Phase 3
0.7602 Intermediate Similarity NPD5473 Discontinued
0.7593 Intermediate Similarity NPD2748 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD2144 Approved
0.756 Intermediate Similarity NPD6827 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD1567 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD6828 Phase 2
0.7558 Intermediate Similarity NPD1708 Approved
0.7558 Intermediate Similarity NPD3038 Discontinued
0.7558 Intermediate Similarity NPD1707 Approved
0.7552 Intermediate Similarity NPD9392 Approved
0.7552 Intermediate Similarity NPD9396 Approved
0.755 Intermediate Similarity NPD1251 Discontinued
0.755 Intermediate Similarity NPD803 Phase 1
0.7545 Intermediate Similarity NPD2390 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD3961 Discontinued
0.7535 Intermediate Similarity NPD269 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2719 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2720 Phase 1
0.7529 Intermediate Similarity NPD2406 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD1598 Discontinued
0.7515 Intermediate Similarity NPD4112 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD1332 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5962 Phase 2
0.75 Intermediate Similarity NPD1993 Approved
0.75 Intermediate Similarity NPD2875 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1995 Approved
0.75 Intermediate Similarity NPD1994 Approved
0.75 Intermediate Similarity NPD6288 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3830 Phase 1
0.7486 Intermediate Similarity NPD7619 Phase 3
0.7486 Intermediate Similarity NPD7618 Phase 3
0.7485 Intermediate Similarity NPD2150 Discontinued
0.7485 Intermediate Similarity NPD2478 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6148 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7564 Discontinued
0.7471 Intermediate Similarity NPD5892 Approved
0.7468 Intermediate Similarity NPD5671 Approved
0.7457 Intermediate Similarity NPD1895 Discontinued
0.7443 Intermediate Similarity NPD8431 Approved
0.744 Intermediate Similarity NPD4640 Approved
0.744 Intermediate Similarity NPD4638 Approved
0.744 Intermediate Similarity NPD4639 Approved
0.7429 Intermediate Similarity NPD4298 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD6375 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD947 Approved
0.7415 Intermediate Similarity NPD748 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6664 Approved
0.7401 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD5255 Approved
0.7391 Intermediate Similarity NPD5538 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD6816 Phase 3
0.7375 Intermediate Similarity NPD1528 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD4922 Phase 2
0.7368 Intermediate Similarity NPD3859 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD3583 Phase 2
0.7362 Intermediate Similarity NPD1917 Discontinued
0.7358 Intermediate Similarity NPD3401 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD2466 Phase 3
0.7346 Intermediate Similarity NPD2462 Phase 3
0.7346 Intermediate Similarity NPD2465 Approved
0.7345 Intermediate Similarity NPD7394 Phase 2
0.7337 Intermediate Similarity NPD4318 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7424 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD2868 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD749 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD3348 Phase 2
0.7326 Intermediate Similarity NPD6044 Discontinued
0.7326 Intermediate Similarity NPD2751 Phase 1
0.7325 Intermediate Similarity NPD680 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data